Effettuare il login Iscriviti gratis

180 Life Sciences Quick ratio

Cos'è Quick ratio di 180 Life Sciences?

Quick ratio di 180 Life Sciences Corp. è 0.58

Qual è la definizione di Quick ratio?



Rapporto rapido è il rapporto di liquidità che misura la capacità di un'azienda di utilizzare i suoi assets rapidi per soddisfare immediatamente le sue obbligazioni a breve termine.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio di aziende nel Health Care settore su NASDAQ rispetto a 180 Life Sciences

Cosa fa 180 Life Sciences?

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Aziende con quick ratio simili a 180 Life Sciences